Skip to main content
TRUPTrupanion, Inc.Sell4.8·$26.87-0.15%
SellModerate Confidence
Investment thesis

Trupanion operates in pet insurance with a 41% analyst-implied upside and a 5.91x risk/reward ratio, but has missed earnings estimates in 3 of the last 4 quarters, burns significant cash at -53% of net income relative to free cash flow, and sits below its long-term moving averages — creating high-risk speculative exposure.

Thesis pillars

  • Cash Burn Fcf Quality ConcernStable
  • Analyst Upside PotentialStable
  • Earnings Miss Execution RiskStable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Trupanion, Inc. (TRUP) Stock Analysis

Recovery setup · Inst Constrain edge

SellModerate Confidence

Financial Services · Insurance - Property & Casualty

Sell if holding. Engine safety override at $26.87: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10 and A.R:R 1.7:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 11%; Below-average business quality; Below long-term trend.

Trupanion provides medical insurance for cats and dogs in the United States, Canada, and parts of Continental Europe through a vertically integrated, data-driven subscription model, alongside a lower-margin 'other business' segment that includes third-party underwriting for Pets... Read more

$26.87+25.8% A.UpsideScore 4.8/10#31 of 39 Insurance - Property & Casualty
QualityF-score8 / 9FCF yield-1.16%
Stop $24.99Target $33.79(analyst − 15%)A.R:R 1.7:1
Analyst target$39.75+47.9%4 analysts
$33.79our TP
$26.87price
$39.75mean
$52

Sell if holding. Engine safety override at $26.87: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10 and A.R:R 1.7:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 11%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 73. Score 4.8/10, moderate confidence.

Passes 7/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 36d clear, semi cycle peak clear, materials cycle peak clear). Suitability: speculative.

10-K grounded · weekly refresh

About Trupanion, Inc.

About Trupanion, Inc.

Trupanion generated $989.3 million in subscription business revenue in 2025 from 1,096,173 enrolled pets, representing approximately 69% of the company's total revenue, with the remainder from a lower-margin other business segment built around third-party underwriting relationships including Pets Best Insurance Services. The company underwrites pet medical insurance in the United States through American Pet Insurance Company, licensed in all 50 states, Puerto Rico, and the District of Columbia, and in Canada through GPIC Insurance Company, while its Bermuda-domiciled subsidiary WICL reinsures policies in Germany and Switzerland.

Trupanion prices its subscription plans on a cost-plus basis tailored to each pet's breed, age, geography, and coverage level, targeting a 71% value proposition — returning 71% of collected premiums to members as claims payments — funded by a low-cost, vertically integrated operating model that pays veterinary invoices directly through proprietary, patented software. The company invested $85.4 million in new pet acquisition expense in 2025 to grow its member base, relying heavily on independent-contractor Territory Partners who are paid based on enrollment and retention activity in their regions to educate veterinarians about the product. Its lower-margin other business segment is anchored by a long-standing underwriting relationship with Pets Best that the company expects will continue to shrink as Pets Best shifts to other underwriters, alongside smaller programs including the U.S. Department of Veterans Affairs and employer-sponsored plans.

Show full overview

Trupanion's non-core other business segment faces a structural headwind: the company's largest source of revenue within that segment comes from its underwriting relationship with Pets Best, which the 10-K states it expects will continue to decline as Pets Best shifts enrollment to other underwriters, meaning that segment's revenue base is expected to shrink even as the core subscription business grows. In Canada, Trupanion is still transitioning underwriting from its long-time fronting partner Accelerant Insurance Company to its own wholly owned GPIC Insurance Company, with Accelerant continuing to underwrite a minority portion of Canadian policies and Trupanion required to fund a trust account, which held CAD $8.7 million as of December 31, 2025, to support that fronting arrangement until the transition completes.

See also: Financial Services · Insurance - Property & Casualty

From Trupanion, Inc.'s most recent 10-K filing, extracted July 6, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-07-07

Recent Developments — Trupanion, Inc.

Generated 2026-07-07T11:41:57Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Aug 10, 202636d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Product: subscription business segment (69.0%)
Quality below floor (3.0 < 4.0)

Key Metrics

P/E (TTM)45.6
P/E (Fwd)6.2
Mkt Cap$1.2B
EV/EBITDA24.3
Profit Mgn1.7%
ROE7.1%
Rev Growth12.3%
Beta1.39
DividendNone
Rating analysts12

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.00neutral
IV63%elevated

Concentration Risks(10-K Item 1A)

  • HIGHProductsubscription business segment69%
    10-K Item 1A: 'For the year ended December 31, 2025, we generated approximately 69% of our revenue from our subscription business segment.'

Material Events(8-K, last 90d)

  • 2026-04-27Item 5.02LOW
    Director Max Brodén notified Trupanion on April 22, 2026 that he will not stand for re-election at the June 10, 2026 Annual Meeting, citing personal reasons and no disagreement with the company or Board; Aflac's strategic partnership with Trupanion is unaffected.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

4 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
0.0
Bollinger
0.2
Support Resistance
0.2

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Erm
5.0
Earnings Timing
5.0
Earnings concerns: 1B/3M

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Fcf Quality
0.0
Gross Margin
0.5
Operating Margin
0.5
Net Margin
0.9
Roa
1.0
Roe
2.4
Current Ratio
6.2
Moat
6.4
Piotroski F
8.9
Earnings quality RED FLAG: -53% FCF/NIStrong Piotroski F-Score: 8/9Quality concerns

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.6
Value Rank
4.4
Growth Rank
7.2
GatesDeath cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 6.1>=5.5A.R:R 1.7 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 36d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Speculative
RSI
73 · Overbought
20D MA 50D MA 200D MADEATH CROSSSupport $21.47Resistance $26.98

Price Targets

$25
$34
A.Upside+25.8%
A.R:R1.7:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.0 < 4.0)

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-08-10 (36d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is TRUP stock a buy right now?

Sell if holding. Engine safety override at $26.87: Quality below floor (3.0 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.8/10 and A.R:R 1.7:1 is above the 1.5:1 BUY gate. Specifically: High short interest: 11%; Below-average business quality; Below long-term trend. Chart setup: Death cross but MACD improving, RSI 73. Prior stop was $24.99. Score 4.8/10, moderate confidence.

What is the TRUP stock price target?

Take-profit target: $33.79 (+25.8% upside). Prior stop was $24.99. Stop-loss: $24.99.

What are the risks of investing in TRUP?

Concentration risk — Product: subscription business segment (69.0%); Quality below floor (3.0 < 4.0).

Is TRUP overvalued or undervalued?

Trupanion, Inc. trades at a P/E of 45.6 (forward 6.2). TrendMatrix value score: 7.4/10. Verdict: Sell.

What do analysts say about TRUP?

12 analysts cover TRUP with a consensus score of 4.0/5. Average price target: $40.

What does Trupanion, Inc. do?Trupanion provides medical insurance for cats and dogs in the United States, Canada, and parts of Continental Europe...

Trupanion provides medical insurance for cats and dogs in the United States, Canada, and parts of Continental Europe through a vertically integrated, data-driven subscription model, alongside a lower-margin 'other business' segment that includes third-party underwriting for Pets Best Insurance Services. As of December 31, 2025, the company had 1,096,173 pets enrolled and generated $989.3 million in subscription business revenue, representing approximately 69% of total 2025 revenue, underwritten primarily through its licensed U.S. subsidiary American Pet Insurance Company and Canadian subsidiar

Related stocks: SLDE (Slide Insurance Holdings, Inc.) · ASIC (Ategrity Specialty Insurance Co) · PLMR (Palomar Holdings, Inc.) · ORI (Old Republic International Corp) · STC (Stewart Information Services Co)
Home Stocks TRUP

Latest news

Latest News

Benzinga68d agoEarnings
Benzinga68d agoEarnings
Benzinga68d agoEarnings
Benzinga68d ago
Benzinga68d agoEarnings
Benzinga84d agoAnalyst
Benzinga89d agoAnalyst